• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Overview of the Drug Registration and Listing System (DRLS & eDRLS) Webinar – May 12, 2011


The Food and Drug Administration, Center for Drug Evaluation and Research (CDER) Small Business Assistance Program is delighted to inform you of a unique opportunity for small business entities to learn more about the FDA and basic drug regulation. Our webinar series will highlight various aspects of drug regulation.
These focused webinars will support the Program’s mission of promoting productive interaction with regulated industry by assisting regulated domestic and international small pharmaceutical business with information relating to the development and regulation of human drug products.
On Thursday, May 12, 2011, we presented our webinar titled 'Overview of the Drug Registration and Listing System (DRLS & eDRLS)' which discussed pertinent regulations and guidances, and submission sequences of the electronic registration and listing process.
Overview of the Drug Registration and Listing System (DRLS & eDRLS) was presented by Paul Loebach, Team Leader for the Drug Registration and Listing Team in the Division of Compliance Risk Management & Surveillance (DCRMS), Office of Compliance, CDER.
For More Information:
Click on Workshops and Webinars in Spotlight box

If you've never used Connect Pro, get a quick overview:
Test your connection prior to the day of the event:
Adobe, the Adobe logo, Acrobat and Acrobat Connect are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.